“immunotherapy” Archives

in
Entry Author Date Location
Bio Roundup: Pharma M&A, AbbVie’s Cancer Bet, Biofourmis Bucks & More 09/04/20 National
Nestlé to Swallow Up Peanut Allergy Drug Maker Aimmune in $2.6B Deal 08/31/20 San Francisco
Bristol Myers Squibb to Splash Out $475M on Dragonfly Immunotherapy 08/17/20 New York
Freeline Therapeutics and Checkmate Pharma Make Opening IPO Moves 07/21/20 Europe
Two Days, Six IPOs, and $1B Raised for Biotech Research & More 07/17/20 National
Bio Roundup: Moderna Publishes, Life Science Cash, AdComm Votes & More 07/17/20 National
Bristol Myers Pays Dragonfly $55M to Bring NK Cells to Neuro Diseases 07/06/20 Boston
With Peanut Patch in FDA Purgatory, DBV Plans Layoffs to Stretch Cash 06/26/20 National
Bio Roundup: ASCO Opens, Merck Takes On COVID, Evofem’s Approval & More 05/29/20 National
Encouraging Signals for New Cancer Cell Therapy Strategies 05/06/20 National
Creating Consistent Value in Biotech Without Diluting Stakeholders 04/07/20 National
Fate Inks $100M Deal With Janssen for Stem Cell-Derived Cancer Therapies 04/03/20 San Diego
Bio Roundup: Clinical Trials Paused, New MS Drug, Kallyope’s Cash & More 03/27/20 National
Palforzia Peanut Allergy Immunotherapy: Aimmune CEO on REMS, Manufacturing 03/24/20 National
Bio Roundup: Pandemic Declared, Rubius Restarts, Kymera’s Cash & More 03/13/20 National
Harbour BioMed Tacks on $75M to Advance Broad Biologics Pipeline 03/12/20 Boston
Silverback Therapeutics Adds $79M to Test HER2+ Tumor-Targeting Drug 03/11/20 Seattle
Aimmune Awarded First FDA Approval for a Peanut Allergy Therapy 01/31/20 San Francisco
Incyte Commits $900M to MorphoSys for Rights to Lymphoma Drug 01/13/20 National
Merck Ramps Up KRAS Chase Through Licensing Deal With Taiho, Astex 01/06/20 New York
No More Fish or Fruit: Intrexon Turns SynBio Focus to Human Health 01/02/20 National
Scripps Research, AbbVie Expand Drug Discovery Deal Beyond Cancer 12/10/19 San Diego
Roche Notches FDA Nod in Lung Cancer, Amps Up Competition With Merck 12/04/19 San Francisco
Ferring and Blackstone Team Up to Fund Gene Therapy Firm With $570M 11/25/19 Boston
ArsenalBio Launches With $85M for “Programmable” T Cell Therapies 10/17/19 San Francisco
Eli Lilly Drug Acquired in Armo Deal Fails Pancreatic Cancer Test 10/16/19 Indiana
ESMO 2019: PARP and Prostate, SeaGen’s Win, KRAS Update & More 10/01/19 National
Biotech Roundup: Vaping Toll Rises, NASH News, Akcea Shakeup & More 09/27/19 National
Gilliland to Step Down as Head of Fred Hutch in 2020 09/17/19 Seattle
FDA Doesn’t Shell Peanut Allergy Drug Pre-Hearing, Aimmune Shares Climb 09/11/19 San Francisco
Page 1 of 9 next page »